| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | CN101111522A Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| 01/23/2008 | CN101111521A Humanized antibody specific for tumor necrosis factor-alpha |
| 01/23/2008 | CN101111511A Process for protein isolation |
| 01/23/2008 | CN101111264A Stabilized liquid polypeptide formulations |
| 01/23/2008 | CN101111227A Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 01/23/2008 | CN101108881A An antibody which recognizes phosphorylated polypeptides |
| 01/23/2008 | CN101108880A Polyclonal antibody for distinguishing legionnella clinical strain and environment strain and method of preparing the same |
| 01/23/2008 | CN101108877A Nucleic acids and proteins from streptococcus pneumoniae |
| 01/23/2008 | CN100363497C Process for preparing PGRP (31-98) fragment by gene recombining technique |
| 01/23/2008 | CN100363054C Cancer therapy using whole glucan particles and antibodies |
| 01/22/2008 | US7321026 Framework-patched immunoglobulins |
| 01/22/2008 | US7320894 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 01/22/2008 | US7320880 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 01/22/2008 | US7320875 Screening for neutralizing hepatitis C virus antibodies in a blood sample utilizing an HCV E2 protein and a protein from a human or chimpanzee cell that has a molecular weight of 24 kd that binds to the E2 protein of HCV; comparing the amount of bound proteins to that in the absence of HCV antibodies |
| 01/22/2008 | US7320873 for diagnosing autoimmune disease (rheumatoid arthritis) activity using monoclonal antibodies |
| 01/22/2008 | US7320870 Identifying a nucleic acid sequence encoding a lacritin receptor by contacting transfected cells with lacritin and detecting calcium signaling |
| 01/22/2008 | US7320869 Antibodies to Chemokine Alpha-5 |
| 01/22/2008 | US7320868 Leptin binding domain compositions and methods thereto |
| 01/22/2008 | US7320863 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/22/2008 | US7320861 Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320792 Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist |
| 01/22/2008 | US7320791 Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules |
| 01/22/2008 | US7320790 Humanized antibodies |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | CA2436779C Human mitochondrial proteins and polynucleotides encoding the proteins |
| 01/22/2008 | CA2380569C Chimeric polypeptides, method for production and uses thereof |
| 01/22/2008 | CA2185516C Homogeneous gene probe test using a receptor directed against the label |
| 01/22/2008 | CA2185114C Recombinant humanized anti-lewis y antibodies |
| 01/17/2008 | WO2008009002A2 Reagents for the detection of protein phosphorylation in signaling pathways |
| 01/17/2008 | WO2008008553A2 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 01/17/2008 | WO2008008482A2 Altered br3-binding polypeptides |
| 01/17/2008 | WO2008007804A1 ANTIHUMAN α9 INTEGRIN ANTIBODY AND USE OF THE SAME |
| 01/17/2008 | WO2008007755A1 Cell death inducer |
| 01/17/2008 | WO2008007648A1 Method of classifying antigen, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same |
| 01/17/2008 | WO2008006554A2 Glyco-engineered antibodies |
| 01/17/2008 | WO2008006363A2 Treatment of t-cell carcinomas using bcl11b inhibitors |
| 01/17/2008 | WO2008006235A2 Scfv antibodies which pass epithelial and/or endothelial layers |
| 01/17/2008 | WO2007136764A9 A cmos linear voltage/current dual-mode imager |
| 01/17/2008 | WO2007117577A3 High affinity human antibodies to human il-18 receptor |
| 01/17/2008 | WO2007105110A3 Ercc1 expression in predicting response for cancer chemotherapy |
| 01/17/2008 | WO2007081906A9 Purification by column-chromatography using eluants containing organic solvents |
| 01/17/2008 | WO2007079448A3 Three component carbohydrate vaccine |
| 01/17/2008 | WO2007075283A3 Polishing steps used in multi-step protein purification processes |
| 01/17/2008 | WO2006105490A3 Compositions and methods for treating diseases associated with phlpp |
| 01/17/2008 | WO2006062779A3 Anti-integrin immunoconjugates, methods and uses |
| 01/17/2008 | WO2006026394A3 Method of eliciting an immune response against hiv |
| 01/17/2008 | WO2005118786A3 Splice variants of peptide yy, neuropeptide y, pancreatic peptide y and amylin, and uses thereof |
| 01/17/2008 | WO2005037999A3 Treatment of cancer using antibodies to lrrc15 |
| 01/17/2008 | WO2005021710A3 Chimeric molecules and methods of use |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015339 High affinity fibronectin derivatives |
| 01/17/2008 | US20080015338 Individualized anti-cancer antibodies |
| 01/17/2008 | US20080015337 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 01/17/2008 | US20080015165 Novel polypeptide |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 01/17/2008 | US20080014613 Prokaryotic collagen-like proteins and uses thereof |
| 01/17/2008 | US20080014598 Phospho-specific antibodies to pi3k regulatory subunit and uses thereof |
| 01/17/2008 | US20080014594 Lung-Expressed Polypeptides |
| 01/17/2008 | US20080014593 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 01/17/2008 | US20080014590 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014205 Neutralizing Antibodies to Influenza Viruses |
| 01/17/2008 | US20080014203 Immunoglobulin which binds insulin-like growth factor receptor (IGF-IR ) for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 01/17/2008 | US20080014202 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | US20080014195 Antagonists Of Myelin-Associated Glycoprotein And Their Use In The Treatment And/Or Prevention Of Neurological Diseases |
| 01/17/2008 | US20080014194 Using alpha-synuclein specific monoclonal antibody to diagnose, prevent and treat parkinson's disease |
| 01/17/2008 | US20080014191 Treatment of Protein Misfolding |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | CA2658241A1 Scfv antibodies which pass epithelial and/or endothelial layers |
| 01/17/2008 | CA2657605A1 Glyco-engineered antibodies |
| 01/17/2008 | CA2657576A1 Cancer biomarkers and methods of use thereof |
| 01/17/2008 | CA2657385A1 Cell death inducer |
| 01/17/2008 | CA2657133A1 Anti-human .alpha.9 integrin antibody and use of the same |
| 01/17/2008 | CA2551163A1 Methods for treating inflammatory, autoimmune or bone resorption diseases |
| 01/16/2008 | EP1878805A2 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus |
| 01/16/2008 | EP1878796A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878795A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878794A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878751A2 Single domain - Fc fusion constructs |
| 01/16/2008 | EP1878750A2 Single domain - Fc fusion constructs |
| 01/16/2008 | EP1878749A2 Individulized anti-cancer antibodies |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878747A1 Glyco-engineered antibodies |
| 01/16/2008 | EP1878746A2 Human monoclonal antibodies to epidermal growth factor receptor |
| 01/16/2008 | EP1878742A2 HIV peptides, antigens, vaccine compositions, immunoassay and a method of detecting antibodies induced by HIV |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878439A2 Actinobacillus pleuropneumoniae virulence genes |
| 01/16/2008 | EP1877799A1 Peptides as biomarkers of copd |
| 01/16/2008 | EP1877782A1 Method for identifying cell-specific protein combination patterns |
| 01/16/2008 | EP1877569A1 Predicting treatment response in cancer subjects |
| 01/16/2008 | EP1877445A2 Methods for treating lower motor neuron diseases and compositions for the same |
| 01/16/2008 | EP1877444A2 P-cadherin antibodies |
| 01/16/2008 | EP1877443A2 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 01/16/2008 | EP1877442A2 Antibodies directed against amyloid-beta peptide and methods using same |